Bosentan for the treatment of pulmonary arterial hypertension (II)

By Antoniu Sabina A  

Therapy, Vol. 2, Iss. 6, 2005-11 ,pp. : 849-852

Future Medicine

Access to resources Recommend Favorite

Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension

By Souza Rogerio   Jardim Carlos   Martins Bárbara   Cortopassi Felipe   Yaksic Mateo   Rabelo Rogerio   Bogossian Humberto  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 907-912

Informa Healthcare

Access to resources Recommend Favorite

Successful Treatment of Sarcoidosis-Associated Pulmonary Hypertension with Bosentan

By  

Respiration, Vol. 75, Iss. 2, 2005-11 ,pp. : 211-214

Karger

Access to resources Recommend Favorite

Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients

By Sasayama Shigetake   Satoh Toru   Izumi Tohru   Yoshida Shunji   Kyotani Shingo   Tahara Nobuhiro  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 395-400

Informa Healthcare

Access to resources Recommend Favorite

Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?

By Clozel Martine  

Annals of Medicine, Vol. 35, Iss. 8, 2003-12 ,pp. : 605-613

Informa Healthcare

Access to resources Recommend Favorite